team eliminated almost all early arrhythmic deaths in the next two years we identified myocardial tension patients treated in such units, thereby reducing the early development and heart rate as two important determinants of both MVO [5] and coronary blood flow [6] . In the 2 early 1960s, and now working in my own laboratory at it became clear that tension development and heart rate after we moved there to help start a new medical school. could not be the only important determinants of MVO , Indeed, we were preparing to conduct a large Phase III trial 2 since stimulation of the cardiac adrenergic nerves or the on this approach, when Favolaro and Effler described a administration of sympathomimetic amines increased new operation-coronary artery bypass grafting-which MVO without altering, indeed while often reducing, the was very successful in restoring the balance between 2 product of developed tension and heart rate. We identified myocardial O supply and demand by directly increasing 2 myocardial contractility, as expressed by the maximum supply. This operation immediately made our more invelocity of myocardial shortening of unloaded muscle, i.e. direct approach obsolete. However, our efforts had not V , as the third major determinant of MVO [7] . It was been a waste of time since they had provided us with a max 2 our distinct honor to publish the first paper in the first unique opportunity to study reflex control of the circulation volume of Cardiovascular Research on the relation bein conscious humans [11] . Much more important, however, tween two of the three determinants of MVO , i.e. heart had been an observation on one of our patients with an 2 rate and contractility [8] . implanted carotid sinus nerve stimulator who had returned Simultaneously, in another section of the laboratory, we to the hospital because of an AMI. Contrary to our were studying cardiovascular control by the carotid sinuses instructions, he maintained the stimulator in the active and learned that stimulation of the carotid sinus nerves mode despite severe and prolonged chest pain. I turned the causes reflex venodilatation, thereby reducing ventricular stimulator off but after I left the coronary care unit he had preload [9] and we confirmed earlier observations that such the good sense to turn it on again until I returned to turn it stimulation also reflexly lowers heart rate, ventricular wall off once more. Later, inspection of his electrocardiogram tension and myocardial contractility. Thus, stimulation of showed that his precordial ST segments rose each time I the carotid sinus nerves reflexly reduces all of the deterturned the stimulator off and they became isoelectric when minants of MVO that we had previously elucidated. Dr he reactivated it.
2
Samuel Levine, one of the fathers of American cardiology Before considering the interpretation of this observation, and an eminent cardiologist at the Harvard Medical School it is useful to place it into context. Simply put, it was and the former Peter Bent Brigham (now Brigham and widely assumed in the 1960s that myocardium perfused by Women's) Hospital, had many years earlier described a a vessel which became acutely occluded was irreversibly clinical maneuver to distinguish angina pectoris from noninjured. However, two important early papers had suganginal chest pain. When external massage of the neck in gested that perhaps some opportunity existed for salvaging the region of the bifurcation of the carotid artery relieved infarcting myocardium. In the first of these, Tennant and ongoing chest pain it was very likely to have been angina Wiggers in 1935 temporarily occluded a major coronary pectoris; when it failed it usually was not.
artery and observed that dyskinetic contraction of the ischemic myocardium commenced within seconds. When the duration of ischemia was brief, i.e. less than 20 min, 3 . The reduction of ischemia by carotid nerve normal myocardial contraction returned after reperfusion, stimulation but when it was longer, dyskinesis continued [12] . In 1941, Blumgart et al. [13] pacemaker implanted into the chest wall. On the flight [14] . Thus, the observation in 1968 that ST segment back to Washington it occurred to me that patient-activated elevations were reduced in our patient undergoing an AMI electrical stimulation of the carotid sinus nerves might when his myocardial O demands were lowered by carotid 2 relieve intractable angina. In collaboration with my late sinus nerve stimulation, supported the suggestion that first wife, Nina Starr Braunwald, who was a cardiac myocardial ischemic injury was not necessarily irreversible surgeon at the Institute, as well as with Glick, Epstein and in this situation. Wechsler, we set about to implant radiofrequency pacemakers which stimulated the carotid sinus nerves. It took just 10 weeks from the development of the idea to its 4 . Early efforts to reduce ischemic damage clinical execution and we were gratified that severe angina could be readily relieved [10] necrotic. Simultaneously, we assessed ischemic injury in patients with evolving AMI using a 35-lead precordial electrode system [20] .
While we were aware from the aforementioned studies by Tennant and Wiggers in the 1930s [12] , of Blumgart et al. in the 1940s [13] , and of course our own group's observations in the early 1970s [17] [18] [19] and of the elegant work of Reimer and Jennings [21] in the late 1970s that timely reperfusion could limit damage during evolving MI, it remained for others to develop techniques for myocardial reperfusion in patients. nase to patients at Bellevue Hospital in 1950. At the time, allowed comparisons of the state of myocardial perfusion streptokinase had not yet been well purified and frequently between patients, treatment arms, and even laboratories; caused severe febrile reactions. In 1976, Chazov et al. [23] (4) showed the ability of the surface electrocardiogram to reported the successful lysis of coronary thrombi in predict survival and coronary patency in STEMI patients patients with AMI with intracoronary streptokinase. Two
[36]; (5) characterized the efficacy and safety of TNKyears later, Rentrop et al. [24] achieved patency of acutely tPA, which is likely to become the most widely used occluded coronary arteries by disrupting coronary thrombi thrombolytic [37] ; (6) reported that thrombolytic therapy with a guide wire passed through a catheter. These two can be safely administered in the ambulance, thereby seminal papers were the forerunners of modern reperfusion reducing further the time between the onset of symptoms therapy of AMI, i.e. thrombolysis and primary percutaand reperfusion [38] ; and (7) showed that platelet inhibineous coronary intervention (PCI).
tion with a glycoprotein IIb / IIIa inhibitor can enhance In 1981, we utilized myocardial thallium-201 imaging to early myocardial reperfusion with t-PA [39] . demonstrate that early opening of the infarct-related artery
The combination of early reperfusion, combined with indeed salvages substantial quantities of myocardium in aspirin and anticoagulant therapy, has reduced the early patients with ST segment elevation MI (STEMI) [25] . In mortality of STEMI by one-third, from about 15 to 10%. 1984, the National Heart, Lung and Blood Institute invited However, there clearly is still room for additional progress. me to chair the first Thrombolysis in Myocardial Infarction
We are now studying a carefully blended combination of (TIMI) trial. In this multicenter trial, we compared intherapies that has been termed 'facilitated PCI.' In the travenous streptokinase with the then new thrombolytic ADVANCE MI trial (TIMI-26) we are testing the efficacy agent, tissue plasminogen activator (t-PA), and learned and safety of a reduced dose of TNK-tPA, eptifibatide, a that: (1) t-PA was superior to streptokinase in opening platelet glycoprotein IIb / IIIa inhibitor, aspirin, and low totally occluded coronary arteries [26, 27] ; and (2) that one molecular weight heparin as a 'holding maneuver,' and year survival was greater in STEMI patients in whom the then transporting the patient to a facility where immediate infarct related artery was open (irrespective of how that PCI can be carried out. It is likely that some combination opening was achieved) than in those in whom it remained of pharmacologic management and PCI will become the occluded [28] . Subsequently, in a much larger trial, the standard of care for reducing myocardial ischemic injury in GUSTO investigators demonstrated that t-PA treatment STEMI. was associated with a lower mortality than treatment with
The TIMI Study Group has also focused attention on streptokinase [29] .
unstable angina-non ST segment elevation MI (UA / NSTEMI), very common ischemic conditions that are closely related to STEMI, and also usually caused by a 6 . The TIMI trials coronary thrombus. Unlike STEMI, the thrombus in UA / NSTEMI usually causes a subtotal coronary occlusion. We I have had the privilege of chairing the TIMI Study have learned that: (1) surprisingly, the outcome in patients Group since its inception. As many as 800 hospitals in 32 with UA / NSTEMI is not improved by thrombolytic countries on five continents have been involved in 20 therapy [40] ; (2) low molecular weight heparin, with its completed trials; ten additional trials are ongoing or in the anti-coagulation factor Xa (as well as anti-IIa) activity, is late planning stages. McCabe, Antman and Cannon are superior to unfractionated heparin [41] ; (3) an invasive three of the many talented collaborators in these trials.
therapeutic approach with early mechanical revascularizaAmong the observations made on patients with STEMI, tion is superior to a conservative approach [42] ; (4) the the TIMI Study Group has: (1) developed and championed management of patients with UA / NSTEMI can be facilithe 'open infarct-artery' theory, which holds that early tated by risk stratification, which can be accomplished by a reperfusion of the infarct-related artery results in myocarcombination of clinical assessment [43] , measurement of dial salvage which preserves ventricular function, which in serum troponin [44] , C-reactive protein [45] , and brain turn improves survival [30, 31] ; however, while the benefits natriuretic peptide [46] and even more effectively by a of reperfusion diminish with time from the onset of combination of these three biomarkers [47] . Both ischemic symptoms [32] , even late revascularization may be benefidamage and death in UA / NSTEMI have been declining in cial [30] ; (2) demonstrated reductions in death and rethe last ten years. current infarction with beta-blockers in STEMI patients who received early t-PA [33] ; (3) developed a system for describing epicardial coronary flow on angiography (the 7 . Stunning and hibernation TIMI Flow Grade) [26] , a system that has been universally adopted, and M. Gibson, a member of the group described In 1978, Heyndrickx et al. [48] , working in Vatner's quantitative angiographic assessments for measuring both laboratory, noted in the conscious dog that after a brief epicardial and myocardial blood flow in patients with (15-30 min) period of severe ischemia followed by STEMI [34, 35] . Taken together, these techniques have reperfusion, not long enough to cause myocardial necrosis, the myocardial dysfunction in the ischemic region perrandomized to the ACE inhibitor [57] (Fig. 3) . This sisted for hours following reperfusion. We termed this observation, also, has been amply confirmed in a number condition myocardial stunning [49] and were able to of clinical trials involving more than one hundred thousand identify its presence in many clinical situations, such as patients. ACE inhibition is now standard therapy and post surgical cardiac ischemia, exercise induced ischemia, appears to be very helpful in reducing the myocardial unstable angina and following thrombolytic reperfusion of consequences of ischemic injury for the majority of evolving AMI [50] . We also proposed that chronic stunpatients recovering from AMI. ning, i.e. persistent moderate ischemia-not sufficiently
With the progressive reductions in mortality from AMI, severe to cause myocardial necrosis-could cause prowe are focusing attention on prevention of recurrent MI longed contractile impairment of viable myocardium. This and improving survival of post-MI patients using HmGcondition, which was aptly named 'myocardial hibernaCoA reductase inhibitors. We have reported in the CARE tion' [51, 52] has emerged as an important cause of trial that post-MI patients with average levels of LDLischemic heart failure which can be reversed by revascucholesterol show an improved outcome with statin therapy larization. Hibernating myocardium can be detected by a [58] , not only by lipid lowering, but perhaps also by the variety of imaging techniques, and observational studies statin's anti-inflammatory actions reflected in its ability to suggest that surgical revascularization prolongs survival in reduce C-reactive protein [59] . Currently, we are examinthese patients. I am now chairing an NIH-supported ing in the A to Z (TIMI 21) [60] and in the PROVE IT randomized controlled trial that is testing this hypothesis.
(TIMI 22) trials [61] , whether commencement of statin therapy within days of an acute coronary event improves clinical outcomes further.
. ACE inhibitors and statins
In the 1980s, working with Marc Pfeffer and the late 9 . Conclusions Janice Pfeffer, we observed late remodeling of the left ventricle in rats with MI [53] . There is not only stretching I have been especially fortunate in my professional life of the infarcted tissue, but also expansion and hypertrophy in several respects. I have had outstanding mentors who of the remaining viable myocardium [54] . In 1980, we taught me to focus on significant clinical-scientific probwere fortunate to obtain small quantities of captopril, the lems and to use a variety of approaches and techniques to first angiotensin-converting enzyme inhibitor, and found address them, rather than to become a slave of a single that its administration could greatly reduce this remodeling technique. I have selected for investigation an important [55] . After confirming this observation in patients with MI problem-ischemic impairment of myocardial function, its [56] , we conducted a large multicenter trial, the SAVE treatment and prevention. 
